@tactivatherapeutics.com
Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor approach.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Tactiva Therapeutics is an immuno-oncology company that is at the forefront of cancer immunotherapy. They utilize an innovative dual T cell receptor (TCR) approach to adoptive cell therapy. Led by CEO Jay Zhang, who has extensive experience in the biopharma industry, Tactiva Therapeutics is dedicated to developing groundbreaking treatments for cancer.
The company was founded by prominent individuals in the field of medicine, including Dr. Richard C. Koya and Dr.
Kunle Odunsi. Dr. Koya is a renowned expert in cancer gene therapy and immunotherapy, with years of experience in research and clinical practice.
Dr. Odunsi is the Director of the University of Chicago Medicine Comprehensive Cancer Center and has made significant contributions to ovarian cancer research. Tactiva Therapeutics offers potent cancer immunotherapy solutions that target and eliminate cancer cells.
Their approach involves enhancing T cell function to optimize the body's natural defenses against cancer. With their cutting-edge technology and leading experts, Tactiva Therapeutics is paving the way for the future of cancer treatment. For more information and inquiries, you can get in touch with Tactiva Therapeutics through their contact details provided on their website
Company Type
Privately Held
Company Size
11-50
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories